 Visit the TF Network Sites · Institutional Investor Center · Individual Investor Center |
| Download Plug-In |
| Real
Player 8 Basic Windows Media Player |
| Other Conference Calls |
| Other May 7 Calls Today's Calls |
| Call Details | |||
| Charles River Laboratories, Inc. Earnings Conference Call (Q1 2008) Wed, May 7, 2008, 8:30 am Eastern
| |||
| About Charles River Laboratories, Inc. (NYSE:CRL) | |||
| Charles River Laboratories International, Inc., together with its subsidiaries, provides solutions that advance the drug discovery and development process, including research models and associated services, and outsourced preclinical services worldwide. The company operates in two segments, Research Models and Services (RMS) and Preclinical Services (PCS). The RMS segment involves in the commercial production and sale of research models, principally purpose-bred rats, mice, and other rodents for use by researchers. It also offers new and proprietary, disease-specific rat models used to find new treatments for diseases, such as diabetes, obesity, cardiovascular, and kidney disease. In addition, this segment provides research models services comprising transgenic services, research animal diagnostics, consulting and staffing services, and discovery services. Further, it provides vaccine support and in vitro technology products for the testing of medical devices and injectable drugs for endotoxin contamination. The PCS segment engages in the discovery and development of new drugs, devices, and therapies. It offers toxicology studies; pathology services; bioanalysis, pharmacokinetics, and drug metabolism services; discovery support; biopharmaceuticals services; and clinical services, including Phase I trials in healthy normal and special populations. Charles River Laboratories International serves pharmaceutical and biotechnology companies, as well as government agencies, hospitals, and academic institutions. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts. | |||
More Info: | |||
